» Authors » Naotsugu Ichimaru

Naotsugu Ichimaru

Explore the profile of Naotsugu Ichimaru including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 93
Citations 705
Followers 0
Related Specialties
Top 10 Co-Authors
Published In
Affiliations
Soon will be listed here.
Recent Articles
1.
Ichimaru N, Natori Y, Alloway R, Wojciechowski D, Castillo Almeida N, Futamura K, et al.
Transplantation . 2025 Mar; PMID: 40072882
Background: Kidney transplantation (KT) has dramatically improved the quality of life of patients with end-stage kidney disease. However, the incidence of opportunistic infections has also increased because of immunosuppression. A...
2.
Ma K, Hu X, Nambu K, Ueda D, Ichimaru N, Fujino M, et al.
Sci Rep . 2023 Jul; 13(1):11646. PMID: 37468618
Hydrogen has been reported to act as an antioxidant, anti-apoptosis and anti-inflammatory agent. Coral calcium carried hydrogen (G2-SUISO) is a safer and more convenient form of hydrogen agent than others....
3.
Kobayashi Y, Arai H, Hamamoto Y, Yoshida K, Shimizu S, Yasuhara Y, et al.
Clin Genitourin Cancer . 2023 May; 21(5):e386-e393. PMID: 37244798
Objectives: To investigate the prognostic value of CD68- and CD163-positive macrophages in patients with upper urinary tract urothelial carcinoma (UTUC). Patients And Methods: This retrospective study enrolled 50 patients (34...
4.
Hesaka A, Tsukamoto Y, Nada S, Kawamura M, Ichimaru N, Sakai S, et al.
Kidney360 . 2022 Apr; 2(10):1611-1624. PMID: 35372967
Background: d-serine, a long-term undetected enantiomer of serine, is a biomarker that reflects kidney function and disease activity. The physiologic functions of d-serine are unclear. Methods: The dynamics of d-serine...
5.
Hirano S, Aoki Y, Li X, Ichimaru N, Takahara S, Takefuji Y
Med Gas Res . 2021 May; 11(3):104-109. PMID: 33942780
Although intensity-modulated radiation therapy (IMRT) has been developed as an alternative to conventional radiotherapy, reducing bone marrow damage is limited. Thus, a novel technology is needed to further mitigate IMRT-induced...
6.
Obi Y, Ichimaru N, Sakaguchi Y, Iwadoh K, Ishii D, Sakai K, et al.
Transpl Int . 2021 Apr; 34(7):1212-1225. PMID: 33884674
Anemia and vitamin D deficiency are associated with allograft failure, and hence, are potential therapeutic targets among kidney transplant recipients (KTRs). We conducted a multicenter, two-by-two factorial, open-label, randomized clinical...
7.
Oshiro Y, Harada H, Hasegawa K, Akutsu N, Yoshizumi T, Kawagishi N, et al.
Hepatol Res . 2021 Mar; 51(5):538-547. PMID: 33749100
Aim: Studies regarding changes in antibodies to hepatitis E virus (HEV) after HEV infection in organ transplant patients are limited. This study aimed to clarify HEV infection trends in organ...
8.
Zhao J, Que W, Du X, Fujino M, Ichimaru N, Ueta H, et al.
Front Immunol . 2021 Mar; 11:555996. PMID: 33737923
Allograft rejection has been an obstacle for the long-term survival of patients. CD70, a tumor necrosis factor (TNF) family member critically expressed on antigen-presenting cells and strongly but transiently up-regulated...
9.
Tanaka R, Kakuta Y, Tsutahara K, Nakagawa M, Ichimaru N, Sakaguchi K, et al.
IJU Case Rep . 2020 Nov; 4(1):22-24. PMID: 33230502
Introduction: The data of immunosuppressive therapy management on solid organ transplant recipients with coronavirus disease 2019 are insufficient. We report a kidney transplant recipient who developed coronavirus disease 2019 pneumonia,...
10.
Doi Y, Hamano T, Ichimaru N, Tomida K, Obi Y, Fujii N, et al.
Sci Rep . 2020 Aug; 10(1):13766. PMID: 32792668
Separate assessment of mineral bone disorder (MBD) parameters including calcium, phosphate, parathyroid hormone (PTH), fibroblast growth factor 23 (FGF23), 25-hydroxyvitamin D, and 1,25-dihydroxyvitamin D (1,25D) predict renal outcomes in kidney...